Thieme E-Books & E-Journals -
Pharmacopsychiatry 2015; 48(04/05): e2
DOI: 10.1055/s-0035-1555803
Erratum
© Georg Thieme Verlag KG Stuttgart · New York

The Elimination Rate after Clozapine Overdose in Chinese Schizophrenia Patients: A Population Pharmacokinetics Model Study

Authors

  • A.-N. Li

    1   Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China
    4   Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China
  • F. Dong

    1   Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China
    4   Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China
  • J.-L. He

    1   Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China
    4   Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China
  • D.-W. Shang

    2   Guangzhou Brain Hospital, Guangzhou Huiai Hospital, The Affiliated Brain Hospital of Guangzhou Medical University, Guangzhou, China
  • W. Guo

    1   Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China
    4   Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China
  • W.-B. Li

    1   Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China
    4   Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China
  • W. Lu

    3   Department of Pharmaceutics, School of Pharmaceutical Sciences, Peking University, Beijing, China
  • C.-Y. Wang

    1   Beijing Key Laboratory of Mental Disorders, Department of Psychiatry, Beijing Anding Hospital, Capital Medical University, Beijing, China
    4   Center of Schizophrenia, Beijing Institute for Brain Disorders and Laboratory of Brain Disorders (Capital Medical University), Ministry of Science and Technology, Beijing, China